Literature DB >> 14351604

The influence of unilateral nephrectomy on the development of stilboestrol-induced renal tumours in the male hamster.

E S HORNING.   

Abstract

Entities:  

Keywords:  DIETHYLSTILBESTROL/effects; KIDNEYS/neoplasms; NEOPLASMS/physiology

Mesh：

Substances：

Year:  1954        PMID： 14351604      PMCID： PMC2007969          DOI： 10.1038/bjc.1954.68

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  2 in total

1.  Functional intrasplenic ovarian transplants in monkeys.

Authors:  G van WAGENEN; W U GARDNER
Journal:  Endocrinology       Date:  1950-03       Impact factor: 4.736

2.  Studies on experimental goitre; the transplant-ability of experimental thyroid tumours of the rat.

Authors:  F BIELSCHOWSKY; W E GRIESBACH
Journal:  Br J Cancer       Date:  1949-12       Impact factor: 7.640
  2 in total
  6 in total

1.  HORMONAL TREATMENT OF RENAL ADENOCARCINOMA.

Authors:  H J LEHMANN
Journal:  Br Med J       Date:  1964-08-22

2.  Immunological differences between normal and malignant cells.

Authors:  R C NAIRN; H G RICHMOND; M G McENTEGART; J E FOTHERGILL
Journal:  Br Med J       Date:  1960-11-05

3.  Endocrine factors involved in the induction, prevention and transplantation of kidney tumours in the male golden hamster.

Authors:  E S HORNING
Journal:  Z Krebsforsch       Date:  1956

4.  Decreased incidence of renal cell carcinoma in rats with one kidney ingesting N-4-(4'-fluorobiphenyl)acetamide.

Authors:  M D Reuber
Journal:  Experientia       Date:  1976-02-15

5.  Tumours of many sites induced by injection of chemical carcinogens into newborn mice, a sensitive test for carcinogenesis: the implications for certain immunological theories.

Authors:  F J ROE; K E ROWSON; M H SALAMAN
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640

Review 6.  Heading Towards a Possible Rebirth of the Induced Renal Cell Carcinoma Models?

Authors:  Clarisse R Mazzola; Domenico Ribatti
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.